Senior insider sale
Chief Medical Officer at PYXIS ONCOLOGY, INC. — senior position signals high conviction
$399.0K
141.66K shares
FEINGOLD JAY plans to sell 141.66K shares of PYXIS ONCOLOGY, INC. valued at approximately $399.0K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Restricted Stock Vesting
Compensation
Restricted Stock Vesting
Compensation
Restricted Stock Vesting
Compensation
Restricted Stock Vesting
Compensation
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/31/2023 | Restricted Stock Vesting Compensation | 6.62K | — |
3/13/2023 | Restricted Stock Vesting Compensation | 912.00 | — |
3/3/2023 | Restricted Stock Vesting Compensation | 14.58K | — |
2/13/2023 | Restricted Stock Vesting Compensation | 911.00 | — |
| Total | 23.02K | ||
Completed
Units to sell
27.36K
Market value
$71.4K
Units to sell
30K
Market value
$83.1K
Units to sell
234.00
Market value
$694.63
Units to sell
23.64K
Market value
$71.1K
Units to sell
37.40K
Market value
$116.7K
Planned — Approximate Date
Units to sell
23.02K
Market value
$56.0K
Units
141.66K
Value
$399.0K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
7/21/2023 | 27.36K | $71.4K | — | Completed |
7/11/2023 | 30K | $83.1K | — | Completed |
6/16/2023 | 234.00 | $694.63 | — | Completed |
6/8/2023 | 23.64K | $71.1K | — | Completed |
6/7/2023 | 37.40K | $116.7K | — | Completed |
| Planned — Approximate Date | ||||
7/27/2023 | 23.02K | $56.0K | NASDAQ | Planned |
| Total | 141.66K | $399.0K | ||